osw 1 has been researched along with docetaxel anhydrous in 1 studies
| Studies (osw 1) | Trials (osw 1) | Recent Studies (post-2010) (osw 1) | Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) |
|---|---|---|---|---|---|
| 57 | 0 | 31 | 12,110 | 3,216 | 6,920 |
| Protein | Taxonomy | osw 1 (IC50) | docetaxel anhydrous (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.0014 | |
| Nucleotide-binding oligomerization domain-containing protein 2 | Homo sapiens (human) | 5.0119 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Q; Li, S; Liao, M; Ma, H; Wu, M; Wu, X; Xi, H; Xia, Y; Zhang, Y | 1 |
1 other study(ies) available for osw 1 and docetaxel anhydrous
| Article | Year |
|---|---|
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.
Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Docetaxel; Doxorubicin; Humans; Mice; Phosphatidylinositol 3-Kinases; Triple Negative Breast Neoplasms | 2022 |